Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8791117
APP PUB NO 20110201614A1
SERIAL NO

13043215

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Embodiments of this invention provide methods for therapeutic use of cyclic G-2-Allyl Proline to treat cognitive disorders as well as manufacture of medicaments including tablets, capsules, injectable solutions that are useful for treatment of such conditions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEUREN PHARMACEUTICALS LIMITEDAUCKLAND 1141

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bickerdike, Michael John Auckland, NZ 12 49
Guan, Jian Waitakere, NZ 36 153

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 29, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00